Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

All types of Platelet-Rich Plasma (PRP) can treat hair loss, but homologous PRP works best due to its higher platelet count and growth factors from multiple donors.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Transcutol P best increases Finasteride absorption for hair loss treatment.

Dihydrotestosterone affects hair growth by changing the Wnt/β-catenin pathway, with low levels helping and high levels hindering growth.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The Random Forest algorithm was the most accurate at diagnosing Polycystic Ovarian Syndrome.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.